Oral pulse therapy with vitamin D3 for control of secondary hyperparathyroidism.
作者信息
Feinstein S, Algur N, Drukker A
机构信息
Division of Paediatric Nephrology, Shaare Zedek Medical Centre, Hebrew University-Hadassah Medical School, Jerusalem, Israel.
出版信息
Pediatr Nephrol. 1994 Dec;8(6):724-6. doi: 10.1007/BF00869102.
PMID:7696113
Abstract
Twelve dialysis patients received oral pulse therapy with 1-alpha-hydroxyvitamin D3 in a dose of 0.1 microgram/kg body weight twice weekly and daily calcium carbonate (1.5-3.5 g) for a period of 8-12 months. This treatment was very effective in suppressing secondary hyperparathyroidism without causing hypercalcaemia and/or hyperphosphataemia.
摘要
Zotero 插件